AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s ...

Nimble Therapeutics, formerly NimbleGen Systems, is developing an oral therapy that could treat psoriasis and inflammatory ...

In times of market volatility, driven by geopolitical risks and political uncertainty, dividend growth stocks offer stability ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

But making AbbVie an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of ABBV ...

Shares of AbbVie Inc. ABBV inched 0.10% higher to $173.37 Friday, on what proved to be an all-around mixed trading session ...

The DuoBody platform has attracted multiple collaboration partners, including AbbVie Inc. (ABBV), Janssen, and Pfizer Inc.

Shares of AbbVie Inc. oscillated between gains and losses Friday as the company’s latest acquisition drew mixed reactions ...

Friday announced an agreement to acquire Nimble Therapeutics for a cash payment of $200 million at closing, along ...

The comorbidity burden of alopecia areata includes an increased risk for autoimmune and psychiatric conditions, like ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...